valeant pharmaceuticals international, inc. form 6-k

BIOVAIL CORPORATION INTERNATIONALCONSOLIDATED BALANCE SHEETS(All dollar amounts are expressed in thousands of U.S. dollars)(Unaudited)MARCH 31, DECEMBER 31,1996 1995-------- ------------ASSETSCURRENTCash and short-term deposits $ 28,431 $ 24,323Trade accounts receivable 6,913 6,379Inventories 5,300 3,868Deposits and prepaid expenses 457 176-------- --------41,101 34,746FIXED ASSETS, net 21,157 19,910GOODWILL, net 3,554 3,594PRODUCT RIGHTS, net 2,602 2,617-------- --------$ 68,414 $ 60,867======== ========LIABILITIESCURRENTAccounts payable $ 4,717 $ 5,628Accrued liabilities 6,320 3,043Income taxes payable 883 968Deferred revenue 25,602 22,167Current portion of long-term debt 2,833 2,244-------- --------40,355 34,050-------- --------DEFERRED REVENUE 1,560 4,274-------- --------LONG-TERM DEBT 7,252 7,951-------- --------49,167 46,275-------- --------SHAREHOLDERS' EQUITYShare capital 14,528 14,489Retained earnings (deficit) 4,115 (572)Cumulative translation adjustment 604 675-------- --------19,247 14,592-------- --------$ 68,414 $ 60,867======== ========